Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in EDSA — Edesa Biotech, Inc.

CIK 1000275 TORONTO, A6
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,047
+$6,371 QoQ
Shares Held
1,851
+11.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 33 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. EDSA ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in EDSA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,047 1,851
2026-03-31 $8,676 1,659
2025-12-31 $2,355 1,659
2025-09-30 $4,485 1,816
2025-06-30 $3,686 1,816
2025-03-31 $4,431 1,816
2024-12-31 $3,050 1,816
2024-09-30 $7,729 1,737
2024-06-30 $7,434 1,737
2024-03-31 $7,278 1,737
2023-12-31 $991 217
2023-09-30 $866 1,375
2023-06-30 $1,113 1,375
2023-03-31 $1,251 1,375
2022-12-31 $3,090 1,431
2022-09-30 $1,316 1,431
2022-06-30 $2,303 1,431
2022-03-31 $4,250 1,431
2021-12-31 $10,871 1,931
2021-09-30 $10,560 1,431
2021-06-30 $1,747 331
2021-03-31 $1,787 331
2020-12-31 $238 56
2020-09-30 $451 56
2020-06-30 $274 56
2020-03-31 $119 56